BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 27, 2018
View Archived Issues
Sumitomo Dainippon and JCR sign CNS license agreement
Read More
RV3-BB administered at birth or to infants prevents severe rotavirus gastroenteritis
Read More
Merrimack initiates phase II trial of MM-121 in postmenopausal metastatic breast cancer
Read More
Xencor and Selexis sign four commercial license agreements
Read More
ALDA-1 ameliorates myocardial injury after hemorrhagic shock in rats
Read More
IL-23 mediates resistance to anti-TNF therapy in Crohn's disease
Read More
Serum MMP-9 levels linked to relapse in quiescent small bowel Crohn's disease
Read More
TLR1 gene variation tied to melioidosis and increased hospital mortality
Read More
FDA grants priority review to lusutrombopag NDA
Read More
UCB patents MAPT-targeting pyrrolo-dipyridine derivatives
Read More
Arising International divulges new PD-1/PD-L1/CD80 interaction inhibitors
Read More
Daiichi Sankyo submits regulatory filing for esaxerenone in Japan
Read More
Medshine Discovery presents novel S1P1 receptor agonists
Read More
New phase I trial evaluates safety and immunogenicity of Zika virus vaccine candidate VLA-1601
Read More
Eli Lilly patents novel BACE1 inhibitors
Read More
FDA awards orphan drug designation to EHP-102 for Huntington's disease
Read More
Genentech and Roche present new TRPA1 antagonists
Read More
U.S. sites join international trials of MEDI-3902 and MEDI-4893
Read More
FDA grants orphan drug designation to taurolidine for neuroblastoma
Read More
AbbVie initiates phase II trial of ABT-165 plus FOLFIRI in colorectal cancer
Read More
Durect initiates phase IIa trial of DUR-928 in primary sclerosing cholangitis
Read More
Bavarian Nordic collaborates to study CV-301 with durvalumab in colorectal and pancreatic cancers
Read More
Enrollment open in phase I trial of MK-5890
Read More
ObsEva reports topline results from phase III trial of nolasiban in IVF
Read More
FDA approves Verzenio as initial treatment for advanced breast cancer
Read More
ARCA reports phase IIb study results for Gencaro in atrial fibrillation
Read More
DBV reports preliminary results from phase II portion of MILES study with Viaskin Milk
Read More
RaQualia completes phase I trial of RQ-00310941
Read More